International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey
Research output: Contribution to journal › Journal article › Research › peer-review
Wendy P J den Elzen, Anne A Lefèbre-van de Fliert, Vanessa Virgini, Simon P Mooijaart, Peter Frey, Patricia M Kearney, Ngaire Kerse, Christian D Mallen, Vera J C McCarthy, Christiane Muth, Thomas Rosemann, Audrey Russell, Henk Schers, David J Stott, Margot W M de Waal, Alex Warner, Rudi G J Westendorp, Nicolas Rodondi, Jacobijn Gussekloo
BACKGROUND: There is limited evidence about the impact of treatment for subclinical hypothyroidism, especially among older people.
AIM: To investigate the variation in GP treatment strategies for older patients with subclinical hypothyroidism depending on country and patient characteristics.
DESIGN AND SETTING: Case-based survey of GPs in the Netherlands, Germany, England, Ireland, Switzerland, and New Zealand.
METHOD: The treatment strategy of GPs (treatment yes/no, starting-dose thyroxine) was assessed for eight cases presenting a woman with subclinical hypothyroidism. The cases differed in the patient characteristics of age (70 versus 85 years), vitality status (vital versus vulnerable), and thyroid-stimulating hormone (TSH) concentration (6 versus 15 mU/L).
RESULTS: A total of 526 GPs participated (the Netherlands n = 129, Germany n = 61, England n = 22, Ireland n = 21, Switzerland n = 262, New Zealand n = 31; overall response 19%). Across countries, differences in treatment strategy were observed. GPs from the Netherlands (mean treatment percentage 34%), England (40%), and New Zealand (39%) were less inclined to start treatment than GPs in Germany (73%), Ireland (62%), and Switzerland (52%) (P = 0.05). Overall, GPs were less inclined to start treatment in 85-year-old than in 70-year-old females (pooled odds ratio [OR] 0.74 [95% confidence interval [CI] = 0.63 to 0.87]). Females with a TSH of 15 mU/L were more likely to get treated than those with a TSH of 6 mU/L (pooled OR 9.49 [95% CI = 5.81 to 15.5]).
CONCLUSION: GP treatment strategies of older people with subclinical hypothyroidism vary largely by country and patient characteristics. This variation underlines the need for a new generation of international guidelines based on the outcomes of randomised clinical trials set within primary care.
|Journal||British Journal of General Practice|
|Number of pages||12|
|Publication status||Published - Feb 2015|